0
Cyclerion Therapeutics, Inc. Banner Image

Cyclerion Therapeutics, Inc.

  • Ticker CYCN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Cyclerion Therapeutics, Inc. Logo Image
  • 51-200 Employees
  • Based in Cambridge, Massachusetts
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of sGC pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Lead programs include its vascular-targeted olinciguat in Phase 2 development for sickle cell disease and IW-6463, a pioneering CNS-penetrant sGC stimulator in clinical development forMore Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like episodes (MELAS) and Alzheimer's Disease with Vascular pathology (ADv)
Cyclerion Therapeutics, Inc.

Most Recent Annual Report

Cyclerion Therapeutics, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Older/Archived Annual Reports